Although four genes (CD5L, IGF2, UROC1, and SLC22A10) were shown to be correlated with HCC-A stage in above analyses, only CD5L, IGF2, and UROC1 were analyzed for further validation since no data were found for SLC22A10 in the two datasets. This evidence concerns the gene SLC22A10 and hepatocellular carcinoma.